PO-0835: Contact Radiotherapy For Lentigo Maligna And Lentigo Maligna Melanoma: A Cohort Of 61 Cases
A. Lamoureux(Hôpital Saint Eloi), V. Vendrely(Centre Hospitalier Universitaire de Bordeaux), R. Trouette(Centre Hospitalier Universitaire de Bordeaux), A. Pham-Ledard, Caroline Dutriaux(Centre Hospitalier Universitaire de Bordeaux), O. Cogrel(Centre Hospitalier Universitaire de Bordeaux), N. Ouhabrache, E. Gérard(Université de Bordeaux), M. Beylot‐Barry, L. Dousset(Centre Hospitalier Universitaire de Bordeaux), S. Coulibaly
Cited by 2
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
|New England Journal of Medicine|2017|1.5k